| dc.contributor.author | Atay, M. Hilmi | |
| dc.contributor.author | Ozatli, Duzgun | |
| dc.contributor.author | Kelkitli, Engin | |
| dc.contributor.author | Yildiz, Levent | |
| dc.contributor.author | Turgut, Mehmet | |
| dc.contributor.author | Guler, Nil | |
| dc.contributor.author | Toptas, Tayfur | |
| dc.date.accessioned | 2020-06-21T14:04:55Z | |
| dc.date.available | 2020-06-21T14:04:55Z | |
| dc.date.issued | 2013 | |
| dc.identifier.issn | 0309-0167 | |
| dc.identifier.issn | 1365-2559 | |
| dc.identifier.uri | https://doi.org/10.1111/his.12125 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/15740 | |
| dc.description | Kelkitli, Engin/0000-0001-7342-1760 | en_US |
| dc.description | WOS: 000329278300017 | en_US |
| dc.description | PubMed: 23879574 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Wiley-Blackwell | en_US |
| dc.relation.isversionof | 10.1111/his.12125 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemia | en_US |
| dc.type | letter | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 63 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.startpage | 293 | en_US |
| dc.identifier.endpage | 294 | en_US |
| dc.relation.journal | Histopathology | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
